Effect of washed versus unwashed red blood cells on transfusion‐related immune responses in preterm newborns
Files
(Published version)
Date
2022
Authors
Crawford, T.M.
Andersen, C.C.
Hodyl, N.A.
Robertson, S.A.
Stark, M.J.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Clinical & Translational Immunology, 2022; 11(3):1-13
Statement of Responsibility
Tara M Crawford, Chad C Andersen, Nicolette A Hodyl, Sarah A Robertson and Michael J Stark
Conference Name
Abstract
Objectives. Transfusion with washed packed red blood cells (PRBCs) may be associated with reduced transfusion-related proinflammatory cytokine production. This may be because of alterations in recipient immune responses. Methods. This randomised trial evaluated the effect of transfusion with washed compared with unwashed PRBCs on pro-inflammatory cytokines and endothelial activation in 154 preterm newborns born before 29 weeks’ gestation. Changes in plasma cytokines and measures of endothelial activation in recipient blood were analysed after each of the first three transfusions. Results. By the third transfusion, infants receiving unwashed blood had an increase in IL-17A (P = 0.04) and TNF (P = 0.007), whereas infants receiving washed blood had reductions in IL-17A (P = 0.013), TNF (P = 0.048), IL-6 (P = 0.001), IL-8 (P = 0.037), IL-12 (P = 0.001) and IFN-c (P = 0.001). The magnitude of the post-transfusion increase in cytokines did not change between the first and third transfusions in the unwashed group but decreased in the washed group for IL-12 (P = 0.001), IL-17A (P = 0.01) and TNF (P = 0.03), with the difference between the groups reaching significance by the third transfusion (P < 0.001 for each cytokine). Conclusion. The proinflammatory immune response to transfusion in preterm infants can be modified when PRBCs are washed prior to transfusion. Further studies are required to determine whether the use of washed PRBCs for neonatal transfusion translates into reduced morbidity and mortality.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© 2022 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.